Zeposia 0.92 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQR2M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,219
Award facts
- Contract value 100% obligated
- $29,218.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $29,218.50. This firm fixed-price delivery order, with an ultimate completion date of December 23, 2025, represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is executing this order under its existing prime indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.9 million value through December 2026.
Zeposia is a specialty pharmaceutical treatment used primarily for autoimmune conditions, reflecting AmerisourceBergen's established role in supplying specialized medications to support military healthcare programs. The delivery order represents a continuation of the contractor's comprehensive pharmaceutical supply operations for the federal government, demonstrating its capacity to fulfill specialized medical requirements within tight performance timelines. AmerisourceBergen's position as a primary pharmaceutical vendor for DLA underscores the critical role private sector distributors play in maintaining the supply chain for military and veteran healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQR2M?
SPE2DR26FQR2M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FQR2M worth?
The government has obligated $29,219 on SPE2DR26FQR2M.
Is contract SPE2DR26FQR2M an order under another contract?
Yes. SPE2DR26FQR2M is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR2M competed?
The extent of competition for SPE2DR26FQR2M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award